Kaleido Biosciences Inc (KLDO)
OTHER OTC:KLDO
US Market
Holding KLDO?
Track your performance easily

Kaleido Biosciences (KLDO) Income Statement

196 Followers

Kaleido Biosciences Income Statement

Last quarter (Q ), Kaleido Biosciences's total revenue was $488.00K, an increase of 100.82% from the same quarter last year. In Q, Kaleido Biosciences's net income was $-20.57M. See Kaleido Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 21Dec 20Dec 19Dec 18Dec 17
Total Revenue
$ 1.10M$ 1.10M$ 975.00K-$ 0.00$ 0.00
Cost of Revenue
------
Gross Profit
$ 1.10M$ 1.10M$ 975.00K---
Operating Expense
$ 88.77M$ 88.77M$ 79.85M$ 86.66M$ 60.68M$ 27.03M
Operating Income
$ -87.67M$ -87.67M$ -78.87M$ -86.66M$ -60.68M$ -27.03M
Net Non Operating Interest Income Expense
$ -2.77M$ -2.77M$ -2.55M$ 716.00K$ 113.00K$ -403.00K
Other Income Expense
$ 145.00K$ 145.00K$ 193.00K$ 387.00K$ -1.17M$ -126.00K
Pretax Income
$ -90.58M$ -90.58M$ -81.62M$ -86.33M$ -61.74M$ -27.56M
Tax Provision
------
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -90.58M$ -90.58M$ -81.62M$ -86.33M$ -61.74M$ -27.56M
Basic EPS
----$ -2.10$ -1.23
Diluted EPS
$ -2.16$ -2.16$ -2.44$ -3.36$ -2.10$ -1.23
Basic Average Shares
$ 166.67M$ 41.86M$ 33.45M$ 25.70M$ 29.39M$ 22.42M
Diluted Average Shares
$ 166.67M$ 41.86M$ 33.45M$ 25.70M$ 29.39M$ 22.42M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 88.77M$ 88.77M$ 79.85M$ 86.66M$ 60.68M$ 27.03M
Net Income From Continuing And Discontinued Operation
$ -90.30M$ -90.30M$ -81.62M$ -86.33M$ -61.74M$ -27.56M
Normalized Income
----$ -60.83M$ -27.45M
Interest Expense
----$ 1.00M$ 435.00K
EBIT
$ -87.74M$ -87.74M$ -78.82M$ -85.35M$ -60.74M$ -27.12M
EBITDA
$ -84.68M$ -84.68M$ -76.30M$ -84.00M$ -59.95M$ -26.81M
Currency in USD

Kaleido Biosciences Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis